Pharmacy-Based Model Enabling Patient Self-Monitoring of Warfarin: Development and Evaluatio
Not Applicable
- Conditions
- In Australia there is currently no pathway to enable consumers taking warfarin who are suitable to perform patient self-monitoring (PSM) of the International Normalised Ratio (INR) to be trained and provided with on-going support.Blood - Haematological diseases
- Registration Number
- ACTRN12608000374369
- Lead Sponsor
- nit for Medication Outcomes Research and Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients must be willing to participate
Patients must have a history of at least 6 months usage of warfarin
Patients must have a long term indication for warfarin use
Patients must have their GP's consent
Patients must have the dexterity to use the POC device or a competent carer capable of assisting
Exclusion Criteria
Language: non English speaking
Dementia:
Participation in other concurrent trials:
Failure to complete training with the accredited pharmacist or to demonstrate the required competency in the use of the POC device
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method